SARS-CoV-2 Antibody Point-of-Care Testing in Dialysis and Kidney Transplant Patients With COVID-19

RATIONALE & OBJECTIVE: A number of serologic tests for immunoglobulin G (IgG) against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are now commercially available, including multiple lateral flow immunoassays (LFIAs), which have the advantage of being inexpensive and easy to use,...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Kidney Med
Auteurs principaux: Prendecki, Maria, Clarke, Candice, McKinnon, Tom, Lightstone, Liz, Pickering, Matthew C., Thomas, David C., McAdoo, Stephen P., Willicombe, Michelle
Format: Artigo
Langue:Inglês
Publié: Elsevier 2020
Sujets:
Original Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7834810/
https://ncbi.nlm.nih.gov/pubmed/33521621
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.xkme.2020.09.010
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires